Isolation of two forms of an activator protein for the enzymic sphingomyelin degradation from human Gaucher spleen.

Two activator proteins for sphingomyelin degradation were isolated from heat-treated extracts of human Gaucher spleen. The separation was based on the degree of affinity of the activators for ConA-Sepharose. Activator A1, which had affinity for ConA-Sepharose, was purified 1 430-fold, and activator A2, which had no affinity for ConA-Sepharose, 2 140-fold as compared with the original heat-treated extracts. The molecular masses of activator A1 and activator A2 were 6 000 and 3 500 Da, respectively, as determined by dodecyl sulfate electrophoresis, and approximately 5 000 Da as measured in the presence of 8M urea. The two activators had similar properties and a similar but not identical amino-acid composition. Both were shown to form a complex with sphingomyelin and stimulate the degradation of sphingomyelin by normal fibroblast homogenates and by an approximately 1 430-fold purified sphingomyelin phosphodiesterase ("acid sphingomyelinase") from normal human urine. This stimulation was greatly reduced after incubation with pronase E. The enzymic degradation of glucosylceramide and galactosylceramide was not affected by these activators.

[1]  D. Wenger,et al.  Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1). , 1984, Archives of biochemistry and biophysics.

[2]  D. Wenger,et al.  Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases. , 1983, The Journal of clinical investigation.

[3]  S. Roth,et al.  A protein activator of galactosylceramide β-galactosidase , 1982 .

[4]  Kunihiko Suzuki,et al.  Acid Sphingomyelinase of Human Brain: Purification to Homogeneity , 1982, Journal of neurochemistry.

[5]  D. Wenger,et al.  Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1. , 1982, Biochemical and biophysical research communications.

[6]  N. Radin,et al.  Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein). , 1981, Biochimica et biophysica acta.

[7]  K. Sandhoff,et al.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[8]  U. K. Laemmli,et al.  Maturation of the head of bacteriophage T4. I. DNA packaging events. , 1973, Journal of molecular biology.

[9]  F. Studier,et al.  Analysis of bacteriophage T7 early RNAs and proteins on slab gels. , 1973, Journal of molecular biology.

[10]  M. Zinbo,et al.  Kinetic Studies on Gluc-amylase , 1966 .

[11]  N. Hilschmann,et al.  Präparative Auftrennung des tryptischen Hydrolysats eines Proteins mit Hilfe der Hochdruck-Flüssigkeitschromatographie. Die Primärstruktur einer monoklonalen L-Kette vom K-Typ, Subgruppe I (Bence-Jones-Protein Wes) , 1980 .

[12]  H. Christomanou.  Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[13]  K. Sandhoff,et al.  Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. , 1979, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[14]  G. Fischer,et al.  The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. , 1975, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.